NMS-03597812
Asset
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 2,129
- Trials
- 1
- Developer
Indications
1Multiple myeloma
Phase 1, Terminated, NCT05027594, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials2,129
- Evidence for its targets1
- Competitors9
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.